egmn Videos

Dr. George L. Bakris reports that two aldosterone receptor blocking drugs spironolactone and eplerenone have swiftly become important, second-line antihypertensive drugs for obese patients. Mitchel Zoler of Elsevier Global Medical News (EGMN) reports from a meeting of the American Diabetes Association in New York. ... aldosterone receptor blocking drugs spironolactone eplerenone obese obesity hypertension antihypertensive EGMN

Author: FamilyPracticeNews; Tags: aldosterone receptor blocking drugs spironolactone eplerenone obese obesity hypertension antihypertensive EGMN

Dr. George L. Bakris reports that two aldosterone receptor blocking drugs spironolactone and eplerenone have swiftly become important, second-line antihypertensive drugs for obese patients. Mitchel Zoler of Elsevier Global Medical News (EGMN) reports from a meeting of the American Diabetes Association in New York. ... 64673 aldosterone receptor blocking drugs spironolactone eplerenone obese obesity hypertension antihypertensive EGMN

Author: InternalMedicineNews; Tags: 64673 aldosterone receptor blocking drugs spironolactone eplerenone obese obesity hypertension antihypertensive EGMN

Dr. George L. Bakris reports that two aldosterone receptor blocking drugs spironolactone and eplerenone have swiftly become important, second-line antihypertensive drugs for obese patients. Mitchel Zoler of Elsevier Global Medical News (EGMN) reports from a meeting of the American Diabetes Association in New York. ... aldosterone receptor blocking drugs spironolactone eplerenone obese obesity hypertension antihypertensive EGMN

Author: ClinicalEndoNews; Tags: aldosterone receptor blocking drugs spironolactone eplerenone obese obesity hypertension antihypertensive EGMN

Dr. George L. Bakris reports that two aldosterone receptor blocking drugs spironolactone and eplerenone have swiftly become important, second-line antihypertensive drugs for obese patients. Mitchel Zoler of Elsevier Global Medical News (EGMN) reports from a meeting of the American Diabetes Association in New York. ... aldosterone receptor blocking drugs spironolactone eplerenone obese obesity hypertension antihypertensive EGMN

Author: CardiologyNews; Tags: aldosterone receptor blocking drugs spironolactone eplerenone obese obesity hypertension antihypertensive EGMN

Dr. George L. Bakris reports that two aldosterone receptor blocking drugs spironolactone and eplerenone have swiftly become important, second-line antihypertensive drugs for obese patients. Mitchel Zoler of Elsevier Global Medical News (EGMN) reports from a meeting of the American Diabetes Association in New York. ... aldosterone receptor blocking drugs spironolactone eplerenone obese obesity hypertension antihypertensive EGMN

Author: ElsGlobalMedicalNews; Tags: aldosterone receptor blocking drugs spironolactone eplerenone obese obesity hypertension antihypertensive EGMN

Dr. Harold J. Wanebo reports that a neoadjuvant regimen of cetuximab and chemoradiation was linked to significant downstaging of locally advanced esophageal cancer. Bob Finn of Elsevier Global Medical News (EGMN) reports from a meeting on gastrointestinal cancer sponsored by the American Society of Clinical Oncology. ... cetuximab chemoradiation esophageal cancer EGMN ASCO

Author: ElsGlobalMedicalNews; Tags: cetuximab chemoradiation esophageal cancer EGMN ASCO

Dr. Harold J. Wanebo reports that a neoadjuvant regimen of cetuximab and chemoradiation was linked to significant downstaging of locally advanced esophageal cancer. Bob Finn of Elsevier Global Medical News (EGMN) reports from a meeting on gastrointestinal cancer sponsored by the American Society of Clinical Oncology. ... cetuximab chemoradiation EGMN gastrointestinal cancer esophageal

Author: OncologyReport; Tags: cetuximab chemoradiation EGMN gastrointestinal cancer esophageal

Dr. Sunanda Kane discusses collaborative approaches to the study and treatment of irritable bowel disease. Damian McNamara of Elsevier Global Medical News (EGMN) reports from a meeting sponsored by Rheumatology News and the Skin Disease Education Foundation. ... 64006 egmn irritable bowel disease kane mcnamara rheumatology elsevier global medical news

Author: InternalMedicineNews; Tags: 64006 egmn irritable bowel disease kane mcnamara rheumatology elsevier global medical news

Dr. Mark Cucuzzella discusses an inexpensive intervention to help reduce injuries in recreational runners. Heidi Splete of Elsevier Global Mecial News (EGMN) reports from the annual meeting of the North American Primary Care Research Group. ... EGMN Elsevier global medical news running injuries splete cucuzzella

Author: RheumatologyNews; Tags: EGMN Elsevier global medical news running injuries splete cucuzzella

Dr. Mark Cucuzzella discusses an inexpensive intervention to help reduce injuries in recreational runners. Heidi Splete of Elsevier Global Mecial News (EGMN) reports from the annual meeting of the North American Primary Care Research Group. ... EGMN Elsevier global medical news running injuries splete cucuzzella

Author: FamilyPracticeNews; Tags: EGMN Elsevier global medical news running injuries splete cucuzzella